abstract |
The present invention relates to novel indazole compounds of formula (I) wherein R 1 is alkyl or cycloalkyl; A and B are as in formula (II)) (the stereoisomers thereof and those Including pharmaceutically acceptable salts thereof. The invention also relates to methods for producing such compounds and pharmaceutical compositions comprising such compounds. The compounds of the present invention are useful in the treatment of various diseases associated with 5-hydroxytryptamine 4 (5-HT 4 ) receptor agonists. |